In contrast, the study by Aukema and colleagues showed that the MYC partner (IG versus non-IG) had no prognostic significance in MYC rearrangement positive B-cell lymphoma (excluding Burkitt lymphoma) [9]. This evidence concerns the gene MYC and Burkitt lymphoma.